Northern Trust
CADL icon

Northern Trust’s Candel Therapeutics CADL Stock Holding History

Northern Trust’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.07M Buy
492,465
+169,311
+52% +$1.28M ﹤0.01% 2617
2026
Q1 		$1.58M Buy
323,154
+27,716
+9% +$151K ﹤0.01% 3099
2025
Q4 		$1.67M Sell
295,438
-11,337
-4% -$61K ﹤0.01% 3104
2025
Q3 		$1.56M Buy
306,775
+18,912
+7% +$109K ﹤0.01% 3169
2025
Q2 		$1.46M Buy
287,863
+52,327
+22% +$269K ﹤0.01% 3181
2025
Q1 		$1.33M Buy
235,536
+70,515
+43% +$576K ﹤0.01% 3142
2024
Q4 		$1.43M Buy
165,021
+6,250
+4% +$36.9K ﹤0.01% 3208
2024
Q3 		$1.1M Buy
158,771
+115,326
+265% +$716K ﹤0.01% 3323
2024
Q2 		$269K Buy
43,445
+23,938
+123% +$180K ﹤0.01% 3750
2024
Q1 		$30.8K Sell
19,507
-110
-0.6% -$163 ﹤0.01% 4294
2023
Q4 		$28.8K Hold
19,617
– – ﹤0.01% 4328
2023
Q3 		$18K Hold
19,617
– – ﹤0.01% 4345
2023
Q2 		$24.7K Hold
19,617
– – ﹤0.01% 4369
2023
Q1 		$26.5K Buy
19,617
+5,134
+35% +$10K ﹤0.01% 4400
2022
Q4 		$25.9K Hold
14,483
– – ﹤0.01% 4433
2022
Q3 		$45K Hold
14,483
– – ﹤0.01% 4345
2022
Q2 		$47K Buy
14,483
+1,028
+8% +$4.12K ﹤0.01% 4426
2022
Q1 		$68K Hold
13,455
– – ﹤0.01% 4454
2021
Q4 		$105K Buy
+13,455
New +$131K ﹤0.01% 4401

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust's CADL Position: Q2 2026 in Review

Northern Trust increased its Candel Therapeutics (CADL) stake by 52% in Q2 2026, buying an estimated $1.28M and bringing the position to 492,465 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Northern Trust first reported a position in CADL in Q4 2021 and has held it in 19 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Northern Trust held 492,465 shares of Candel Therapeutics worth $5.07M as of Q2 2026.
  • Northern Trust bought 169,311 Candel Therapeutics shares in Q2 2026, an estimated $1.28M.
  • Candel Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2617 holding.
  • Northern Trust first reported a position in Candel Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.